Baseline demographics and characteristicsa
| CTA Group (n = 87) | DSA Group (n = 94) | P Value | |
|---|---|---|---|
| Age (yr) (mean) | 66.5 ± 11.4 | 67.2 ± 13.0 | .708 |
| Female sex | 28 (32.2) | 37 (39.4) | .315 |
| Hypertension | 50 (57.5) | 55 (58.5) | .887 |
| Diabetes | 27 (31.0) | 18 (19.1) | .065 |
| Hyperlipidemia | 4 (4.6) | 2 (2.1) | .430 |
| Smoking | 18 (20.7) | 19 (20.2) | .937 |
| Prior stroke | 23 (26.4) | 15 (16.0) | .084 |
| Atrial fibrillation | 10 (11.5) | 47 (50.0) | .000 |
| Heart failure | 1 (1.1) | 10 (10.6) | .010 |
| CKD | 0 (0.0) | 0 (0.0) | 1.000 |
| Previous use of contrast | 4 (4.6) | 3 (3.2) | .712 |
| NSAID | 11 (12.6) | 9 (9.6) | .511 |
| Baseline NIHSS (median) (IQR) | 3 (2–4) | 14 (10–19) | .000 |
| Hemoglobin (mean) (g/L) | 137.9 ± 16.0 | 133.5 ± 16.4 | .707 |
| WBC count (mean) (× 109/L) | 7.4 ± 2.6 | 8.0 ± 2.7 | .121 |
| rtPA | 38 (43.7) | 28 (29.8) | .052 |
| mRS score at 3 mo of <3 | 85 (97.7) | 86 (91.5) | .102 |
Note:—CKD indicates chronic kidney dysfunction; NSAID, nonsteroidal anti-inflammatory drugs; IQR, interquartile range; WBC, white blood cells; BUN, blood urea nitrogen.
↵a Data are number and percentage unless otherwise indicated.